This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.
Tiffany Tam, PharmD, BCOP
Advertisement
Articles by Tiffany Tam, PharmD, BCOP
Advertisement
Latest Updated Articles
A Review of Anti-HER2 Targeted Agents in Non-Breast Solid TumorsPublished: February 14th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Icotrokinra Outperforms Deucravacitinib in Head-to-Head Psoriasis Study
2
Dato-DXd Shows Promise as First-Line Therapy in Metastatic TNBC
3
From Policy to Practice: How the ACC Legislative Conference Advances Cardiovascular Care
4
FDA Approves Roflumilast Cream for Pediatric Patients With Atopic Dermatitis
5
